Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elobixibat for chronic constipation in patients with heart failure
jRCTs071190055Completed
- Sponsor
- EA Pharma Co., Ltd.
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of elobixibat in heart failure (HF) and chronic constipation, sponsored by EA Pharma Co., Ltd. Started Aug 2020; status: completed.
02
Drugs
elobixibat
03
Conditions
heart failure (HF)chronic constipation
Beyond the preview
Go deeper on jRCTs071190055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071190055.